Insight manufacturing plant consists of separate suites for the manufacturing of multi-product biologics bulk drug substances (BDS) and chemical synthesis active pharmaceutical ingredients (APIs). The plant is equipped with state-of-the-art manufacturing equipment that enables us to meet  the needs of global pharmaceutical industry.

InSight’s manufacturing plant includes 2,000 sqm of modern FDA and EMA-compliant manufacturing facilities for Multi-product Mammalian-derived biological bulk drug substances (BDS) and for chemical active pharmaceutical ingridient (API).